Full-Time

Lead – Clinical Operations

Confirmed live in the last 24 hours

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

201-500 employees

Develops treatments for neurodegenerative diseases

Biotechnology
Healthcare

Senior

Remote in USA

Must reside and work within the United States in a state where Amylyx currently does business.

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
Requirements
  • BS/BA Degree, in science or a health-related field is preferred
  • Minimum 8 years of clinical operations experience in a pharmaceutical/biotech, and/or CRO setting;
  • Experience and understanding of global clinical trial operations; study startup through close-out; strong vendor management skills; inspection-ready mind-set
  • Effective project management skills with a demonstrated ability to provide critical and timely insight, and analytical problem-solving skills
  • Ability to manage competing priorities, is detail-oriented and comfortable multi-tasking
  • Exceptional knowledge of GCP, ICH and FDA regulations
  • Must be able to travel up to 20%, domestically and internationally
  • Ability to work independently in a rapidly changing, small company environment and comfortable making risk-based decisions
  • Therapeutic experience in rare diseases or CNS conditions is preferred
Responsibilities
  • Directly responsible for the conduct of the trials from start-up through close-out, with close attention to effective planning and execution, risk management, data integrity, quality and compliance with Company SOPs, ICH-GCP guidelines, GDPR, and other regulations and patient safety standards.
  • Ensures appropriate operational procedures are implemented or adhered to, to assure high quality trial data and operational excellence of assigned studies.
  • Develops, analyses, and reports on metrics for clinical programs.
  • In conjunction with Clinical Leadership, ensures study deliverables are achieved on time and within budget.
  • Contributes to the development of study documentation including protocol review, study manuals, ICFs, CRFs, Clinical Study Reports etc.
  • Communicates trial status, issues, mitigations, and lessons learned to relevant cross-functional stakeholders, including senior leadership.
  • Stakeholder in CRO and vendor selection. Works with clinical operations leadership, clinical outsourcing, legal, and finance in the selection and contracting of CROs and vendors. Oversees and contributes to financial reporting for assigned projects including but not limited to PO management, projections, actuals and accruals.
  • Manages relationships and establishes strong partnerships with CROs, vendors, investigators, and other external partners.
  • Addresses and/or escalates vendor performance issues; identifies probable vendor risks and potential mitigation strategies.
  • Develops SOPs, work instructions, and standardized forms to define Clinical Operations processes within a growing team.
  • Provides leadership and support to direct report(s), if applicable, including mentoring, training, performance evaluation, and career development.
Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

View

Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, focusing on conditions like Amyotrophic Lateral Sclerosis (ALS) and Alzheimer's Disease (ALZ). Their main product, AMX0035, is currently undergoing clinical trials, including the CENTAUR ALS trial, which showed significant benefits for ALS patients through a randomized, double-blind, placebo-controlled study. They are also conducting the PEGASUS trial to assess AMX0035's safety and effectiveness for Alzheimer's patients. Unlike many competitors, Amylyx emphasizes community engagement and awareness campaigns, such as ALS Awareness Month, to educate the public and foster support for those affected by these diseases. The company's goal is to bring effective therapies to market that improve patient outcomes.

Company Stage

IPO

Total Funding

$166.7M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

-38%

1 year growth

-33%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful acquisition of Phase 3-ready avexitide from Eiger could diversify Amylyx's pipeline and open new revenue streams.
  • Interim data from the Phase 2 HELIOS trial shows promising results for AMX0035 in treating Wolfram syndrome, indicating potential for broader applications.
  • The appointment of experienced professionals like Dr. Bernhardt Zeiher to the Board of Directors strengthens the company's leadership and strategic direction.

What critics are saying

  • The failure of the Phase III PHOENIX trial and subsequent market withdrawal of Relyvrio raises concerns about the efficacy of Amylyx's treatments.
  • A significant workforce reduction by 70% under a restructuring plan could impact company morale and operational efficiency.

What makes Amylyx Pharmaceuticals unique

  • Amylyx Pharmaceuticals focuses on neurodegenerative diseases like ALS and Alzheimer's, setting it apart from competitors with broader therapeutic areas.
  • The company's flagship product, AMX0035, has shown significant treatment benefits in rigorous clinical trials, including the CENTAUR ALS trial, which is a strong validation of its efficacy.
  • Amylyx's commitment to community engagement and awareness campaigns, such as ALS Awareness Month, enhances its brand and builds a supportive community around its cause.

Help us improve and share your feedback! Did you find this helpful?